VEGFA and pulmonary arterial hypertension: However, unlike bevacizumab, SU5416 blocks VEGF receptors, platelet derived growth factor (PDGF) receptor, c - Kit (stem cell factor receptor), and RET (tyrosine kinase receptor), not VEGF itself, causes emphysema as well as pulmonary hypertension [7].